Cure MSA

Country specific patient information

Rome

Principal investigator:
Prof. Alfredo Berardelli

Department of Neurology and Psychiatry,
Sapienza University Rome,
Rome, Italy
alfredo.berardelli(at)uniroma1.it


Expertise of the participating organization:

The Rome group has a long time interest in the clinical assessment and the medical treatment of patients suffering from parkinsonism. In the last five years the group has been actively involved in the study of the epidemiology and genetic involvement in atypical parkinsonism. Among different forms of atypical parkinsonism, MSA is the one more frequently encountered at our centre.

Recent publications relevant to the EMSA-SG:

Colosimo C, Berardelli A. Autonomic failure and reduced survival in multiple system atrophy. Brain 2015;138:3466-3468.

 

Suppa A, Marsili L, Di Stasio F, Latorre A, Parvez AK, Colosimo C, Berardelli A. Primary motor cortex long-term plasticity in multiple system atrophy. Mov Disord 2014;29:97-104.

 

Bologna M, Marsili L, Khan N, Parvez AK, Paparella G, Modugno N, Colosimo C, Fabbrini G, Berardelli A. Blinking in patients with clinically probable multiple system atrophy. Mov Disord 2014;29:415-420.

 

Rocchi L, Conte A, Nardella A, Li Voti P, Di Biasio F, Leodori G, Fabbrini G, Berardelli A. Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease. Eur J Neurol 2013;20:714-719.

 

Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J Urol 2009;182:1453-1457.

 

Pezzella FR, Colosimo C, Vanacore N, Di Rezze S, Chianese M, Fabbrini G, et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005; 20: 77-81. 

 

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Case-control study of multiple system atrophy. Mov Disord 2005; 20: 158-63.

 

Colosimo C, Vanacore N, Bonifati V, Fabbrini G, Rum A, De Michele G, et al. Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand 2001; 103: 261-4.

 

Fabbrini G, Barbanti P, Bonifati V, Colosimo C, Gasparini M, Vanacore N, et al. Donepezil in the treatment of progressive supranuclear palsy. Acta Neurol Scand 2001; 103: 123-5. 

 

Vanacore N, Bonifati V, Colosimo C, Fabbrini G, De Michele G, Marconi R, et al. Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci 2001; 22: 101-3.

 

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci 2001; 22: 97-9. 

 

Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 2000; 54: 114-9.